- $68.54m
- $75.28m
- $129.42m
- 50
- 52
- 79
- 63
Annual income statement for GAN, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30 | 35.2 | 124 | 142 | 129 |
Cost of Revenue | |||||
Gross Profit | 22.9 | 24.7 | 82.8 | 99.9 | 90.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 27.4 | 54.6 | 155 | 334 | 160 |
Operating Profit | 2.59 | -19.5 | -31.2 | -193 | -30.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.58 | -19.9 | -30.8 | -194 | -34.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2 | -20.2 | -30.6 | -197 | -34.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 2 | -20.2 | -30.6 | -197 | -34.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2 | -20.2 | -30.6 | -197 | -34.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.106 | -0.749 | -0.674 | -2.09 | -0.793 |